a month ago
BCRX
AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Sectors:
Analyst Ranking
Top 11%
#534 out of 5181 analysts
Average Return
+23.5%
Win Rate
68%27 out of 40
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Day One Biopharmaceuticals IncDAWN | +112.76% | $5.80 | $12.34 | 2025-08-05 - 2026-01-22 | Buy |
Savara IncSVRA | +112.50% | $3.04 | $6.46 | 2025-08-14 - 2026-01-22 | Buy |
Arvinas IncARVN | +101.44% | $6.24 | $12.57 | 2025-08-06 - 2026-01-22 | Buy |
Palvella Therapeutics IncPVLA | +94.67% | $47.30 | $92.08 | 2025-08-14 - 2026-01-22 | Buy |
Savara IncSVRA | +88.89% | $3.42 | $6.46 | 2025-09-02 - 2026-01-22 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Metavia IncMTVA | 2 | Buy | $40.00 | +1,333.69% | Maintains | 17 days ago |
Savara IncSVRA | 3 | Buy | $10.00 | +54.80% | Maintains | a month ago |
Wave Life Sciences LtdWVE | 2 | Buy | $30.00 | +117.08% | Maintains | a month ago |
Insmed IncINSM | 2 | Buy | $230.00 | +43.40% | Maintains | a month ago |
Dbv Technologies SaDBVT | 3 | Buy | $40.00 | +73.61% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $198.00 | +44.14% | Maintains | a month ago |
Palvella Therapeutics IncPVLA | 4 | Buy | $200.00 | +117.20% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $32.00 | +374.07% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 3 | Buy | $134.00 | +84.14% | Maintains | a month ago |
Kamada LtdKMDA | 1 | Buy | $13.00 | +62.91% | Maintains | a month ago |
Fulcrum Therapeutics IncFULC | 3 | Buy | $25.00 | +126.24% | Maintains | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $620.00 | +24.49% | Maintains | 2 months ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Hold | $9.00 | +18.58% | Maintains | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 3 | Buy | $30.00 | +190.14% | Maintains | 3 months ago |
Liquidia CorpLQDA | 2 | Buy | $50.00 | +21.74% | Maintains | 3 months ago |
United Therapeutics CorpUTHR | 1 | Buy | $525.00 | +11.21% | Maintains | 3 months ago |
Akero Therapeutics IncAKRO | 2 | Hold | $54.00 | -1.19% | Downgrades | 3 months ago |
89bio IncETNB | 2 | Hold | $14.50 | -2.29% | Downgrades | 4 months ago |
Terns Pharmaceuticals IncTERN | 1 | Hold | $7.44 | -79.32% | Assumes | 5 months ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +43.20% | Maintains | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +102.59% | Maintains | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $478.00 | +2.28% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.